Reaffirms Outlook
Q3 Highlights
- Total revenues of $29.2 million, up 43% year-over-year
- Total revenues in constant currency of $30.1 million; up 48% year-over-year
- Gross margin of 58%, compared to 62% for the prior-year period
- Net income of $1.2 million, compared to net income of $0.4 million for the prior-year period
- Adjusted EBITDA of $4.5 million, compared to $2.1 million for the prior-year period
- Adjusted EPS of $0.09, compared to $0.03 for the prior-year period
Luna Innovations Incorporated (NASDAQ: LUNA), a global leader in advanced optical technology, today announced its financial results for the three and nine months ended September 30, 2022.
"I'm extremely pleased with our performance in Q3, achieving over 40% growth in revenues and more than doubling Adjusted EBITDA versus last year," said Scott Graeff, President and Chief Executive Officer of Luna. "The team was able to achieve these strong financial results while still navigating a challenging supply chain and economic environment. And I’m particularly pleased that this quarter is more normative, positively reflecting the meaningful strategic moves and investments we’ve made over the past two years to refine Luna’s focus and realign our organization appropriately. Today, Luna Innovations is uniquely positioned to offer a breadth of solutions and capabilities in fiber technology.”
Graeff continued, “With three quarters now behind us, we feel very comfortable that we will finish 2022 within the ranges that we provided on our March earnings call. As always, we remain focused on execution, both to capitalize on important growth trends and to advance our strategy of Enabling the Future with Fiber.”
Third-Quarter Fiscal 2022 Financial Summary
Highlights of the financial results for the three months ended September 30, 2022 are:
|
|
Three Months Ended September 30, |
|
Change |
|||||||
(in thousands, except share and per share data) |
|
|
2022 |
|
|
|
2021 |
|
|
|
|
Revenues |
|
$ |
29,153 |
|
|
$ |
20,329 |
|
|
43 |
% |
|
|
|
|
|
|
|
|||||
Gross profit |
|
|
16,919 |
|
|
|
12,584 |
|
|
34 |
% |
Gross margin |
|
|
58 |
% |
|
|
62 |
% |
|
|
|
|
|
|
|
|
|
||||||
Operating expense |
|
|
15,441 |
|
|
|
12,594 |
|
|
23 |
% |
Operating income/(loss) |
|
|
1,478 |
|
|
|
(10 |
) |
|
|
|
Operating margin |
|
|
5 |
% |
|
|
— |
% |
|
|
|
|
|
|
|
|
|
||||||
Other expense, net and income tax expense |
|
|
(310 |
) |
|
|
(334 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Net income/(loss) from continuing operations |
|
$ |
1,168 |
|
|
$ |
(344 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Income from discontinued operations, net of income taxes |
|
|
28 |
|
|
|
699 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income |
|
$ |
1,196 |
|
|
$ |
355 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Income per diluted share (EPS) |
|
$ |
0.04 |
|
|
$ |
0.01 |
|
|
|
|
Adjusted EPS |
|
$ |
0.09 |
|
|
$ |
0.03 |
|
|
200 |
% |
Diluted weighted average shares outstanding |
|
|
34,104,850 |
|
|
|
33,780,714 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA |
|
$ |
4,544 |
|
|
$ |
2,110 |
|
|
115 |
% |
A reconciliation of Adjusted EPS and Adjusted EBITDA to the nearest comparable figures under generally accepted accounting principles ("GAAP") can be found in the schedules included in this release.
Revenues for the three months ended September 30, 2022 increased 43% compared to the prior-year period; 48% on a constant currency basis.
Gross margin was 58% for the three months ended September 30, 2022, compared to 62% for the three months ended September 30, 2021, driven primarily by product mix. Operating income and margin were $1.5 million and 5% of total revenues, respectively, for the three months ended September 30, 2022, compared to an operating loss of $10 thousand dollars and less than 1% of total revenues, respectively, for the three months ended September 30, 2021.
Net income was $1.2 million, or $0.04 per fully diluted share, for the three months ended September 30, 2022, compared to net income of $0.4 million, or $0.01 per fully diluted share, for the three months ended September 30, 2021. Adjusted EPS was $0.09 for the three months ended September 30, 2022 compared to $0.03 for the three months ended September 30, 2021.
Adjusted EBITDA was $4.5 million for three months ended September 30, 2022, compared to $2.1 million for the three months ended September 30, 2021.
Nine Months Ended Fiscal 2022 Financial Summary
Highlights of the financial results for the nine months ended September 30, 2022 are:
|
|
Nine Months Ended September 30, |
|
Change |
|||||||
(in thousands, except share and per share data) |
|
|
2022 |
|
|
|
2021 |
|
|
|
|
Revenues |
|
|
77,795 |
|
|
|
63,291 |
|
|
23 |
% |
|
|
|
|
|
|
|
|||||
Gross profit |
|
|
47,162 |
|
|
|
37,436 |
|
|
26 |
% |
Gross margin |
|
|
61 |
% |
|
|
59 |
% |
|
|
|
|
|
|
|
|
|
||||||
Operating expense |
|
|
50,510 |
|
|
|
41,061 |
|
|
23 |
% |
Operating loss |
|
|
(3,348 |
) |
|
|
(3,625 |
) |
|
|
|
Operating margin |
|
|
(4 |
)% |
|
|
(6 |
)% |
|
|
|
|
|
|
|
|
|
||||||
Other expense, net and income tax benefit |
|
|
231 |
|
|
|
1,061 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net loss from continuing operations |
|
$ |
(3,117 |
) |
|
$ |
(2,564 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Income from discontinued operations, net of income taxes |
|
|
11,543 |
|
|
|
2,371 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income/(loss) |
|
$ |
8,426 |
|
|
$ |
(193 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
Earnings/(loss) per diluted share (EPS) |
|
$ |
0.26 |
|
|
$ |
(0.01 |
) |
|
|
|
Adjusted EPS |
|
$ |
0.12 |
|
|
$ |
0.08 |
|
|
50 |
% |
Diluted weighted average shares outstanding |
|
|
32,492,276 |
|
|
|
33,585,973 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Adjusted EBITDA |
|
$ |
7,450 |
|
|
$ |
4,461 |
|
|
67 |
% |
A reconciliation of Adjusted EPS and Adjusted EBITDA to the nearest comparable GAAP figures can be found in the schedules included in this release.
Revenues for the nine months ended September 30, 2022 increased 23% compared to the prior-year period; 25% on a constant currency basis.
Gross profit of $47.2 million for the nine months ended September 30, 2022 increased from $37.4 million for the nine months ended September 30, 2021 primarily due to higher sales. Operating loss and margin improved to $3.3 million and 4% of total revenues, respectively, for the nine months ended September 30, 2022, compared to $3.6 million and 6% of total revenues, respectively, for the nine months ended September 30, 2021.
Net income was $8.4 million, or $0.26 per fully diluted share, for the nine months ended September 30, 2022, compared to a net loss of $0.2 million, or $(0.01) per fully diluted share, for the nine months ended September 30, 2021. Adjusted EPS was $0.12 for the nine months ended September 30, 2022, compared to $0.08 for the nine months ended September 30, 2021.
Adjusted EBITDA was $7.5 million for the nine months ended September 30, 2022, compared to $4.5 million for the nine months ended September 30, 2021.
2022 Full-Year Outlook
Luna is reaffirming the 2022 revenue and adjusted EBITDA outlook it originally provided on March 14, 2022, which included the mid-March divestiture of Luna Labs and the acquisition of Lios.
- Total revenue of $109 million to $115 million for the full year 2022
- Adjusted EBITDA of $10 million to $12 million for the full year 2022
Luna is not providing an outlook for net income, which is the most directly comparable GAAP measure to Adjusted EBITDA, because changes in the items that Luna excludes from net income to calculate Adjusted EBITDA, such as share-based compensation, tax expense, and significant non-recurring charges, among other things, can be dependent on future events that are less capable of being controlled or reliably predicted by management and are not part of Luna's routine operating activities.
The outlook above does not include any future acquisitions, divestitures, or unanticipated events.
Non-GAAP Financial Measures
In evaluating the operating performance of its business, Luna’s management considers Adjusted EBITDA, Adjusted EPS and revenue measured on a constant currency basis, which are non-GAAP financial measures. Adjusted EBITDA and Adjusted EPS exclude certain charges and income that are required by GAAP. Adjusted EBITDA and Adjusted EPS provide useful information to both management and investors by excluding the effect of certain non-cash expenses and items that Luna believes may not be indicative of its operating performance, because either they are unusual and Luna does not expect them to recur in the ordinary course of its business, or they are unrelated to the ongoing operation of the business in the ordinary course.
The Company calculates revenue measured on a constant currency basis by translating its foreign revenues for the relevant period in U.S. dollars at the average exchange rate in effect for the comparable prior year period. The Company presents revenue in this manner because it is a global company that transacts business in multiple currencies and reports financial information in U.S. dollars. Foreign currency exchange rate fluctuations affect the amounts reported by the Company in U.S. dollars with respect to its foreign revenues. Exchange rate fluctuations can have a significant effect on reported revenues. The Company believes presenting constant currency revenue information provides useful information to investors, as it provides information to assess how its businesses performed excluding the effects of changes in foreign currency exchange rates and assists investors in evaluating the effectiveness of the Company’s operations and underlying business trends in a manner that is consistent with management’s evaluation of business performance.
Adjusted EBITDA, Adjusted EPS and revenue measured on a constant currency basis should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. Adjusted EBITDA and Adjusted EPS have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.
Conference Call Information
As previously announced, Luna will conduct an investor conference call at 5:00 pm (ET) today, November 10, 2022, to discuss its financial results for the three and nine months ended September 30, 2022. The investor conference call will be available via live webcast on the Luna website at www.lunainc.com under the tab "Investor Relations." To participate by telephone, the domestic dial-in number is 1.877.270.2148 and the international dial-in number is.1.412.902.6510. Participants should ask to join the Luna Innovations Incorporated conference call and are advised to dial in at least fifteen minutes prior to the call. A replay of the conference call will be available on the company's website under "Webcasts and Presentations" for 30 days following the conference call.
About Luna
Luna Innovations Incorporated (www.lunainc.com) is a leader in optical technology, providing unique capabilities in high-performance, fiber optic-based, test products for the telecommunications industry and distributed fiber optic-based sensing for a multitude of industries. Luna’s business model is designed to accelerate the process of bringing new and innovative technologies to market.
Forward-Looking Statements
The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include Luna's expectations regarding its projected full year 2022 financial results and outlook, and the Company's ability to capitalize on growth trends. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of Luna may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation, failure of demand for Luna's products and services to meet expectations, failure of target market to grow and expand, technological and strategic challenges, uncertainties related to the ultimate impact of the COVID-19 pandemic and those risks and uncertainties set forth in Luna’s Form 10-Q for the quarter ended September 30, 2022, and Luna's other periodic reports and filings with the Securities and Exchange Commission ("SEC"). Such filings are available on the SEC’s website at www.sec.gov and on Luna’s website at www.lunainc.com. The statements made in this release are based on information available to Luna as of the date of this release and Luna undertakes no obligation to update any of the forward-looking statements after the date of this release.
Luna Innovations Incorporated Consolidated Balance Sheets (Unaudited) (in thousands, except share data) |
|||||||
|
September 30, 2022 |
|
December 31, 2021 |
||||
|
(unaudited) |
|
|
||||
Assets |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
7,889 |
|
|
$ |
17,128 |
|
Accounts receivable, net |
|
29,295 |
|
|
|
20,913 |
|
Contract assets |
|
6,196 |
|
|
|
5,166 |
|
Inventory |
|
32,400 |
|
|
|
22,493 |
|
Prepaid expenses and other current assets |
|
4,744 |
|
|
|
3,793 |
|
Assets held for sale |
|
— |
|
|
|
12,952 |
|
Total current assets |
|
80,524 |
|
|
|
82,445 |
|
Property and equipment, net |
|
4,827 |
|
|
|
2,988 |
|
Intangible assets, net |
|
18,964 |
|
|
|
17,177 |
|
Goodwill |
|
27,215 |
|
|
|
18,984 |
|
Operating lease right-of-use assets |
|
4,069 |
|
|
|
5,075 |
|
Other non-current assets |
|
3,251 |
|
|
|
247 |
|
Deferred tax asset |
|
6,397 |
|
|
|
3,321 |
|
Total assets |
$ |
145,247 |
|
|
$ |
130,237 |
|
Liabilities and stockholders’ equity |
|
|
|
||||
Liabilities: |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Current portion of long-term debt obligations |
$ |
2,250 |
|
|
$ |
4,167 |
|
Accounts payable |
|
5,370 |
|
|
|
2,809 |
|
Accrued and other current liabilities |
|
19,237 |
|
|
|
9,258 |
|
Contract liabilities |
|
4,850 |
|
|
|
4,649 |
|
Current portion of operating lease liabilities |
|
2,115 |
|
|
|
2,101 |
|
Liabilities associated with assets held for sale |
|
— |
|
|
|
9,703 |
|
Total current liabilities |
|
33,822 |
|
|
|
32,687 |
|
Long-term debt obligations, net of current portion |
|
19,465 |
|
|
|
11,673 |
|
Long-term portion of operating lease liabilities |
|
2,374 |
|
|
|
3,509 |
|
Deferred tax liability |
|
1,324 |
|
|
|
— |
|
Other long-term liabilities |
|
408 |
|
|
|
445 |
|
Total liabilities |
|
57,393 |
|
|
|
48,314 |
|
Commitments and contingencies |
|
|
|
||||
Stockholders’ equity: |
|
|
|
||||
Common stock, par value $0.001, 100,000,000 shares authorized, 34,650,827 and 33,855,725 shares issued, 32,865,870 and 32,116,270 shares outstanding at September 30, 2022 and December 31, 2021, respectively |
|
35 |
|
|
|
34 |
|
Treasury stock at cost, 1,784,957 and 1,744,026 shares at September 30, 2022 and December 31, 2021, respectively |
|
(5,542 |
) |
|
|
(5,248 |
) |
Additional paid-in capital |
|
103,264 |
|
|
|
98,745 |
|
Accumulated deficit |
|
(3,149 |
) |
|
|
(11,575 |
) |
Accumulated other comprehensive loss |
|
(6,754 |
) |
|
|
(33 |
) |
Total stockholders’ equity |
|
87,854 |
|
|
|
81,923 |
|
Total liabilities and stockholders’ equity |
$ |
145,247 |
|
|
$ |
130,237 |
|
Luna Innovations Incorporated Consolidated Statements of Operations (Unaudited) (in thousands, except share and per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
||||||||||||
Revenues |
$ |
29,153 |
|
|
$ |
20,329 |
|
|
$ |
77,795 |
|
|
$ |
63,291 |
|
Cost of revenues |
|
12,234 |
|
|
|
7,745 |
|
|
|
30,633 |
|
|
|
25,855 |
|
Gross profit |
|
16,919 |
|
|
|
12,584 |
|
|
|
47,162 |
|
|
|
37,436 |
|
Operating expense: |
|
|
|
|
|
|
|
||||||||
Selling, general and administrative |
|
12,665 |
|
|
|
9,674 |
|
|
|
42,527 |
|
|
|
33,414 |
|
Research, development and engineering |
|
2,776 |
|
|
|
2,920 |
|
|
|
7,983 |
|
|
|
7,647 |
|
Total operating expense |
|
15,441 |
|
|
|
12,594 |
|
|
|
50,510 |
|
|
|
41,061 |
|
Operating income/(loss) |
|
1,478 |
|
|
|
(10 |
) |
|
|
(3,348 |
) |
|
|
(3,625 |
) |
Other income/(expense): |
|
|
|
|
|
|
|
||||||||
Other income |
|
73 |
|
|
|
— |
|
|
|
146 |
|
|
|
— |
|
Interest expense, net |
|
(218 |
) |
|
|
(110 |
) |
|
|
(442 |
) |
|
|
(375 |
) |
Total other expense, net |
|
(145 |
) |
|
|
(110 |
) |
|
|
(296 |
) |
|
|
(375 |
) |
Income/(loss) from continuing operations before income taxes |
|
1,333 |
|
|
|
(120 |
) |
|
|
(3,644 |
) |
|
|
(4,000 |
) |
Income tax expense/(benefit) |
|
165 |
|
|
|
224 |
|
|
|
(527 |
) |
|
|
(1,436 |
) |
Net income/(loss) from continuing operations |
|
1,168 |
|
|
|
(344 |
) |
|
|
(3,117 |
) |
|
|
(2,564 |
) |
Income from discontinued operations, net of income tax (benefit)/expense of ($78), $235, $88 and $381 |
|
28 |
|
|
|
699 |
|
|
|
622 |
|
|
|
2,371 |
|
Gain on sale of discontinued operations, net of tax of $3,117 |
|
— |
|
|
|
— |
|
|
|
10,921 |
|
|
|
— |
|
Net income from discontinued operations |
|
28 |
|
|
|
699 |
|
|
|
11,543 |
|
|
|
2,371 |
|
Net income/(loss) |
$ |
1,196 |
|
|
$ |
355 |
|
|
$ |
8,426 |
|
|
$ |
(193 |
) |
Net income/(loss) per share from continuing operations: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.04 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
Diluted |
$ |
0.03 |
|
|
$ |
(0.01 |
) |
|
$ |
(0.10 |
) |
|
$ |
(0.08 |
) |
Net income per share from discontinued operations: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
— |
|
|
$ |
0.02 |
|
|
$ |
0.36 |
|
|
$ |
0.08 |
|
Diluted |
$ |
— |
|
|
$ |
0.02 |
|
|
$ |
0.36 |
|
|
$ |
0.07 |
|
Net income/(loss) per share attributable to common stockholders: |
|
|
|
|
|
|
|
||||||||
Basic |
$ |
0.04 |
|
|
$ |
0.01 |
|
|
$ |
0.26 |
|
|
$ |
(0.01 |
) |
Diluted |
$ |
0.04 |
|
|
$ |
0.01 |
|
|
$ |
0.26 |
|
|
$ |
(0.01 |
) |
Weighted average shares: |
|
|
|
|
|
|
|
||||||||
Basic |
|
32,800,690 |
|
|
|
31,944,869 |
|
|
|
32,492,276 |
|
|
|
31,553,998 |
|
Diluted |
|
34,104,850 |
|
|
|
33,780,714 |
|
|
|
32,492,276 |
|
|
|
33,585,973 |
|
Luna Innovations Incorporated Consolidated Statements of Cash Flows (Unaudited) (in thousands) |
|||||||
|
Nine Months Ended September 30, |
||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
||||||
Cash flows (used in)/provided by operating activities |
|
|
|
||||
Net income/(loss) |
$ |
8,426 |
|
|
$ |
(193 |
) |
Adjustments to reconcile net income/(loss) to net cash used in operating activities |
|
|
|
||||
Depreciation and amortization |
|
3,993 |
|
|
|
3,523 |
|
Share-based compensation |
|
3,204 |
|
|
|
2,230 |
|
Gain from discontinued operations, net of tax |
|
(10,921 |
) |
|
|
— |
|
Deferred taxes |
|
(3,374 |
) |
|
|
(23 |
) |
Change in assets and liabilities |
|
|
|
||||
Accounts receivable |
|
(6,166 |
) |
|
|
482 |
|
Contract assets |
|
(2,739 |
) |
|
|
837 |
|
Inventory |
|
(6,662 |
) |
|
|
(1,906 |
) |
Other current assets |
|
2,093 |
|
|
|
(1,752 |
) |
Other long-term assets |
|
599 |
|
|
|
— |
|
Accounts payable and accrued and other current liabilities |
|
5,824 |
|
|
|
(1,681 |
) |
Contract liabilities |
|
2,425 |
|
|
|
(287 |
) |
Other long term-liabilities |
|
13 |
|
|
|
— |
|
Net cash (used in)/provided by operating activities |
|
(3,285 |
) |
|
|
1,230 |
|
Cash flows used in investing activities |
|
|
|
||||
Acquisition of property and equipment |
|
(2,313 |
) |
|
|
(943 |
) |
Intangible property costs |
|
4 |
|
|
|
(215 |
) |
Proceeds from sale of property and equipment |
|
25 |
|
|
|
— |
|
Proceeds from sale of discontinued operations |
|
12,973 |
|
|
|
— |
|
Acquisition of Lios |
|
(22,085 |
) |
|
|
— |
|
Net cash used in investing activities |
|
(11,396 |
) |
|
|
(1,158 |
) |
Cash flows provided by/(used in) financing activities |
|
|
|
||||
Payments on finance lease obligations |
|
(36 |
) |
|
|
(36 |
) |
Proceeds from borrowings under debt obligations |
|
22,150 |
|
|
|
— |
|
Payments of debt obligations |
|
(16,275 |
) |
|
|
(3,110 |
) |
Repurchase of common stock |
|
(294 |
) |
|
|
(420 |
) |
Proceeds from ESPP |
|
521 |
|
|
|
530 |
|
Proceeds from the exercise of options |
|
1,160 |
|
|
|
2,076 |
|
Net cash provided by/(used in) financing activities |
|
7,226 |
|
|
|
(960 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
(1,784 |
) |
|
|
277 |
|
Net decrease in cash and cash equivalents |
|
(9,239 |
) |
|
|
(611 |
) |
Cash and cash equivalents-beginning of period |
|
17,128 |
|
|
|
15,366 |
|
Cash and cash equivalents-end of period |
$ |
7,889 |
|
|
$ |
14,755 |
|
Luna Innovations Incorporated Reconciliation of Net Income/(Loss) to EBITDA and Adjusted EBITDA (in thousands) |
||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||
|
|
2022 |
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
|||||||||||
Net income/(loss) |
$ |
1,196 |
|
$ |
355 |
|
|
$ |
8,426 |
|
|
$ |
(193 |
) |
Net income from discontinued operations |
|
28 |
|
|
699 |
|
|
|
11,543 |
|
|
|
2,371 |
|
Net income/(loss) from continuing operations |
|
1,168 |
|
|
(344 |
) |
|
|
(3,117 |
) |
|
|
(2,564 |
) |
Interest expense, net |
|
218 |
|
|
110 |
|
|
|
442 |
|
|
|
375 |
|
Income tax expense/(benefit) |
|
165 |
|
|
224 |
|
|
|
(527 |
) |
|
|
(1,436 |
) |
Depreciation and amortization |
|
1,299 |
|
|
1,131 |
|
|
|
3,993 |
|
|
|
3,440 |
|
EBITDA |
|
2,850 |
|
|
1,121 |
|
|
|
791 |
|
|
|
(185 |
) |
Share-based compensation |
|
1,027 |
|
|
689 |
|
|
|
3,027 |
|
|
|
2,133 |
|
Integration and transaction expense |
|
184 |
|
|
196 |
|
|
|
2,184 |
|
|
|
2,073 |
|
Amortization of inventory step-up |
|
134 |
|
|
104 |
|
|
|
391 |
|
|
|
440 |
|
Other non-recurring charges (1) |
|
349 |
|
|
— |
|
|
|
1,057 |
|
|
|
— |
|
Adjusted EBITDA |
$ |
4,544 |
|
$ |
2,110 |
|
|
$ |
7,450 |
|
|
$ |
4,461 |
|
(1) - Other non-recurring charges include severance, customer accommodation, facility consolidation and debt refinancing costs. |
||||||||||||||
Luna Innovations Incorporated Reconciliation of Net Income/(Loss) to Adjusted EPS (in thousands, except per share data) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
|
|
|
|
||||||||||||
Net income/(loss) |
$ |
1,196 |
|
|
$ |
355 |
|
|
$ |
8,426 |
|
|
$ |
(193 |
) |
Net income from discontinued operations |
|
28 |
|
|
|
699 |
|
|
|
11,543 |
|
|
|
2,371 |
|
Net income/(loss) from continuing operations |
|
1,168 |
|
|
|
(344 |
) |
|
|
(3,117 |
) |
|
|
(2,564 |
) |
Share-based compensation |
|
1,027 |
|
|
|
689 |
|
|
|
3,027 |
|
|
|
2,133 |
|
Integration and transaction expense |
|
184 |
|
|
|
196 |
|
|
|
2,184 |
|
|
|
2,073 |
|
Amortization of intangible assets |
|
988 |
|
|
|
761 |
|
|
|
2,793 |
|
|
|
2,353 |
|
Amortization of inventory step-up |
|
134 |
|
|
|
104 |
|
|
|
391 |
|
|
|
440 |
|
Other non-recurring charges (1) |
|
349 |
|
|
|
— |
|
|
|
1,057 |
|
|
|
— |
|
Income tax effect on adjustments |
|
(671 |
) |
|
|
(438 |
) |
|
|
(2,363 |
) |
|
|
(1,750 |
) |
Adjusted income from continuing operations |
$ |
3,179 |
|
|
$ |
968 |
|
|
$ |
3,972 |
|
|
$ |
2,685 |
|
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
||||||||
Adjusted EPS |
$ |
0.09 |
|
|
$ |
0.03 |
|
|
$ |
0.12 |
|
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
||||||||
Adjusted weighted average shares (in thousands): |
|
|
|
|
|
|
|
||||||||
Diluted |
|
34,105 |
|
|
|
33,781 |
|
|
|
32,492 |
|
|
|
33,586 |
|
(1) - Other non-recurring charges include severance, customer accommodation, facility consolidation and debt refinancing costs. |
|||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005999/en/
Contacts
Investor Contact:
Allison Woody
Phone: 540-769-8465
Email: IR@lunainc.com
